Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

1.1K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.1K
Upper Respiratory Drugs: Decongestants01:27

Upper Respiratory Drugs: Decongestants

493
Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
493
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

1.3K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.3K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

608
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
608
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

1.3K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.3K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

1.4K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacovigilance analysis of cutaneous adverse drug reactions for cetuximab, panitumumab, and necitumumab based on EudraVigilance and WHO VigiAccess.

Frontiers in pharmacology·2026
Same author

Cutaneous Adverse Drug Reactions Associated With BRAF and MEK Inhibitors: A Real-World Analysis of WHO Pharmacovigilance Data.

Clinical pharmacology and therapeutics·2026
Same author

Primary, Secondary and Exploratory Endpoints in Phase 2 and 3 Clinical Trials with Novel Therapies in MASH Cirrhosis: A Systematic Review.

Journal of clinical medicine·2026
Same author

Empathy, Access, and Delays: Determinants of Oncology Care Satisfaction in Polish Academic and Non-Academic Hospitals.

The oncologist·2026
Same author

The Diagnostic Reliability of <i>BIN1</i> and <i>TOMM40</i> Genotyping in Assessing Dementia Risk.

Genes·2025
Same author

ABC Transporters, APOE, CYP46A1, and LRP1 Gene Polymorphisms as Markers of Dementia Development in Patients with Hyperlipidemia.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Nov 3, 2025

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

862

Pseudoephedrine-Benefits and Risks.

Krystyna Głowacka1, Anna Wiela-Hojeńska1

  • 1Department of Clinical Pharmacology, Wroclaw Medical University, Borowska 211a St., 50-556 Wroclaw, Poland.

International Journal of Molecular Sciences
|June 2, 2021
PubMed
Summary

Pseudoephedrine (PSE) is a medication for cold and flu symptoms. However, its stimulant properties lead to misuse as an appetite suppressant, fatigue reducer, and precursor for illicit drug synthesis.

Keywords:
adverse reactionsnon-medical usepseudoephedrinesympathomimetic

More Related Videos

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.7K
Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
06:06

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

25.6K

Related Experiment Videos

Last Updated: Nov 3, 2025

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

862
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.7K
Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
06:06

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

25.6K

Area of Science:

  • Pharmacology
  • Medicinal Chemistry
  • Forensic Science

Background:

  • Pseudoephedrine (PSE) has a long history of medical use for respiratory conditions.
  • Its central nervous system (CNS) stimulant properties and structural similarity to amphetamines contribute to non-medical applications.
  • PSE is readily available and sometimes used as a substitute for amphetamine or methamphetamine.

Purpose of the Study:

  • To review the dual nature of pseudoephedrine (PSE) as a therapeutic agent and a substance of misuse.
  • To highlight its use in non-medical contexts, including as a performance enhancer and illicit drug precursor.
  • To discuss the implications of its availability and potential for misuse.

Main Methods:

  • Literature review of pseudoephedrine's pharmacological properties.
  • Analysis of its chemical structure and relationship to amphetamines.
  • Examination of documented non-medical uses and illicit synthesis pathways.

Main Results:

  • Pseudoephedrine effectively treats cold, flu, sinusitis, asthma, and bronchitis symptoms.
  • Non-medical uses include appetite reduction, fatigue elimination, concentration enhancement, and doping.
  • PSE serves as a precursor in the synthesis of amphetamine and methamphetamine.

Conclusions:

  • Pseudoephedrine possesses significant therapeutic benefits but also carries a high potential for misuse.
  • Its availability poses challenges related to its use as a substitute for and precursor to illicit stimulants.
  • The effectiveness of legal restrictions in curbing pseudoephedrine misuse remains to be determined.